Prostate Specific Antigen (PSA)
appendix, prostate hyperplasia
Regulatory status: IVD, FDA Class I
60-0058-7 7mL RTU
61-0058 1mL concentrate
This antibody which is reactive with the Prostate Specific Antigen (PSA) is a useful tool for identification of adenocarcinoma of the prostate in metastatic sites and for differentiating prostate adenocarcinoma from urothelial carcinoma. This antibody may be useful when used in a panel of antibodies.